Evaluation of serum 8-isoprostane levels and arterial stiffness index in normotensive, prehypertensive and hypertensive subjects
Muhammad Sajid Mehmood, Muhammad Mazhar Hussain, Kamil Asghar Imam.
Abstract
Objective: To compare serum levels of 8-isoprostane and arterial stiffness index (ASI) in normotensive, prehypertensive and hypertensive subjects and to ascertain its correlation with ASI and blood pressure.
Methodology: We studied a total of ninety male subjects ranging from 35-55 years of age. They were classified into normotensive, prehypertensive and hypertensive groups in light of JNC-8 Guidelines. Each group comprised of thirty subjects. Blood pressure was measured with mercury sphygmomanometer and digital volume pulse was recorded by photoplethysmography and ASI was calculated. Serum 8-isoprostane levels were measured by ELISA.
Results: Serum 8-isoprostane levels and ASI were significantly (0.0001) different amongst the three groups. The Post Hoc Tukeys Test revealed p-value of 0.006 between normotensive and prehypertensive groups and 0.0001 between prehypertensive and hypertensive as well as normotensive and hypertensive groups for ASI. Plasma 8-isoprostane levels were non-significant (0.113) between normotensive and prehypertensive groups while significant (0.0001) between prehypertensive and hypertensive as well as normotensive and hypertensive groups. In normotensive subjects, the relationship between serum 8-isoprostane levels was moderately (r=0.4) correlated with ASI while, it was relatively strongly related with ASI in prehypertensive (r = 0.5) and hypertensive (r = 0.5) subjects.
Conclusion: The oxidative stress is involved in the development and worsening of arterial stiffness in prehypertensive and hypertensive patients.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!